Effect of lower limb bioimpedance spectroscopy on determining patient 's dry weight and their cardiovascular parameters.
Not Applicable
- Conditions
- Patients with chronic kidney disease under hemodialysis...Chronic kidney disease, stage 5.
- Registration Number
- IRCT2016090329587N2
- Lead Sponsor
- Vice chancellor for research of Tehran University of Medical Sciences.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 53
Inclusion Criteria
Patients older than 18 years old who have the history of dialysis for more than 3 months. Exclusion criteria: Psychiatric diseases; pregnancy; breastfeeding; stage 4 of congestive heart failure; positive history of myocardial infarction or stroke in past 6 months; having cardiac pacemaker or implant; having knee or hip implant; having deep venous thrombosis or lymph edema in lower limb.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Dry weight. Timepoint: During at frist session of hemodialysis, at third month after patient reaches to her or his gaol dry weight, at sixth month after patient reaches to her or his gaol dry weight. Method of measurement: Lower limb bioimpedance spectroscopy.;Pro b-type Natriuretic Peptide. Timepoint: At baesline and at the end of study (when patient entry to our study and six month later when the study end). Method of measurement: blood analysis.
- Secondary Outcome Measures
Name Time Method